What is the future of dual listings in the US? When is the right time? These are the questions Adam Kostyal sets out to answer in the latest episode of Brännpunkt Life Science.

Brännpunkt Life Science is an interview series in collaboration with DNB Sweden that focuses the magnifying glass on the intersection of innovation, capital and health. In the first part, we meet Adam Kostyal, Head of European Listings at Nasdaq, who looks at the stock market year for the sector, talks about the impact of the pandemic and shares his predictions for the future.

On December 9, Adam will speak at the SwedenBIO Summit 2020 on the theme of Money Talks.
Register here.